Board to appoint new MD after demise of Umesh B. Sandu

Management Changes View source PDF Explain this filing

Price

Loading chart…

▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.

Price reactionminutes from the announcement price · days from the prior close

-0.0%Reaction day

₹41.60

prior close

₹41.60

announcement price

In-mkt

timing

Nifty Microcap 250market · in no size index; the smallest one is used+0.2%-0.2% vs market

Pharmaceuticals peers, median of 164sector-0.5%+0.5% vs sector

On the reaction day the stock moved 0.2 pts less than Nifty Microcap 250 and 0.5 pts more than its Pharmaceuticals peers, over the same two closes: a difference in percentage points, not a measure of what the filing did.

Minutes after the announcementfrom the announcement price · no benchmark

Stock

—

10m

+0.0

15m

+0.0

30m

+0.0

Sessions after the filingfrom the prior close

StockMarketvs marketSectorvs sector

Reaction day

-0.0+0.2-0.2-0.5+0.5

Next day

-0.3-0.5+0.2-0.7+0.4

-0.4-2.5+2.1-1.7+1.3

-2.5-0.6-1.9-1.2-1.3

-1.4+0.7-2.2-0.4-1.0

-1.6+0.9-2.5+0.3-1.9

-1.4+0.5-1.9+0.5-1.9

15d

-5.5-0.2-5.3-1.4-4.1

-8.4+2.9-11.3-1.4-7.0

-7.7+5.0-12.7+1.3-9.0

-11.5+3.7-15.2+0.6-12.1

UpDownMarket · Nifty Microcap 250Sector · Pharmaceuticals peers, median of 164Pending

Minute windows have no benchmark: there is no intraday index history to compare against.

AI summary

Sandu Pharmaceuticals board will meet on 11 July 2026 to record the demise of Managing Director Umesh B. Sandu, who passed away on 19 June 2026. The board will consider appointing a new Managing Director and an additional Independent Director, and reconstitute board committees. Trading window is closed from 1 July 2026 until 48 hours after Q1 results are announced.

Likely market impact

Leadership transition at the top due to MD demise may cause short-term uncertainty, but board appears prepared with succession steps.